Subscribe to Newsletter
Discovery & Development Formulation, Contract Development Services, Small Molecules, Trends & Forecasts

Small Molecules: Expert Insights

sponsored by Cambrex

The small molecule drug development pipeline is booming! And with shrinking clinical trial cohorts (especially in oncology and orphan indications), smaller and virtual companies are now able to take candidates further than ever before. In this eBook, experts from Cambrex discuss the key trends affecting opportunities in the small molecule market – and some of the biggest drug development challenges. David Pearson explains the frustration that can accompany unexpected hydrates of an API, and Ralph N. Landau shares his thoughts on why the pharma industry must move away from a “one-size-fits-all” approach to pediatric formulations.

Click here to download the eBook

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine